24/7 Customer Support

Cancer Pain Diagnostics Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

Global Cancer Pain Diagnostics Market – (By Drug Type - Opioids/Narcotics, Non-Opioids, and Nerve Blocks; By Disease Indication - Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, and Others; and By Region) - Industry Dynamics, Market Size, Opportunity and Forecast to 2030

  • Published On: 30-May-2022  |  Format: pdfpowerpointexcel  |  Report ID: AA0522253
    Delivery: 2 to 4 Hours
INFOGRAPHIC:
Cancer Pain Diagnostics Market

View Full Infographic

FREQUENTLY ASKED QUESTIONS

The Global Cancer Pain Diagnostics Market was valued at US$ 6,716.2 Mn in 2021. 

According to WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.

The most common cancers are breast, lung, colon and rectum and prostate cancers.

The psychological effects of cancer pain can be devastating. Pain makes suffering worse by increasing feelings of helplessness, anxiety, depression, and despair.

The Global Cancer Pain Diagnostics Market is projected to expand at a CAGR of 4.6% during the forecast period. 

The market is majorly driven by factors such as niche penetration of healthcare facilities for cancer diagnostics and rising healthcare expenditure & government support worldwide.

The accessibility to facilities and high cost of treatment may hinder the market growth over the forecast period. 

Rise in number of private diagnostic centers is creating a lucrative opportunity for market growth.

Breast cancer holds the highest share in the Global Cancer Pain Diagnostics Market.

The opioids/narcotics segment holds the highest share in the cancer pain diagnostics market in 2021.

North America dominates the Global Cancer Pain Diagnostics Market.

The key players in the Global Cancer Pain Diagnostics Market are Biodelivery Sciences International Inc., CK life Science (WEX Pharma), Daiichi Sankyo Co. Ltd., Hisamitsu Pharma Co. Inc., and Roche Holding AG among others.